Breaking News Bar

Business News and Information

Moderna reports Covid vaccine, in trial at SLU, is 95% effective, can be stored at higher temperatures

The Massachusetts-based biotech firm says an early look at data from its Covid-19 vaccine's phase 3 trial, in which Saint Louis University is participating, shows it may be more effective than Pfizer’s leading candidate at preventing infection and will be easier to distribute.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
bottom clear